August 5th 2025
The planned acquisition of STAAR includes the EVO family of lenses (EVO ICL) for vision correction for patients with moderate to high myopia with or without astigmatism.
What increased depth of focus can mean to your monofocal IOL patients
December 31st 2024Enhanced monofocal IOLs provide a slight depth-of-focus boost without compromising contrast, making them a versatile choice for patients seeking improved distance and intermediate vision while still needing glasses for near tasks.
Read More
FDA approves Bausch + Lomb’s enVista Envy range of IOLs
October 14th 2024According to the company, enVista Envy IOLs will be commercially available in the U.S. on a limited basis in the coming weeks and more broadly in 2025. Bausch + Lomb is also in the process of seeking regulatory approvals for the lens in additional markets.
Read More
Loyola Medicine ophthalmologists travel to Guatemala to provide advanced eye care
August 4th 2024A team of 14 eyecare professionals made the recent trip including faculty from the Loyola Medicine Department of Ophthalmology and faculty and residents from Cook County Health, Northwestern Medicine, Wills Eye Hospital in Philadelphia, the University of Toledo College of Medicine and Champlain Ophthalmology in Bethesda, Maryland.
Read More
The retrospective cohort study by a team of researchers in China included 58 cataract eyes of 54 patients with corneal astigmatism who underwent phacoemulsification and rotationally asymmetric multifocal intraocular lens implantation. Patients were treated with either an opposite clear corneal incision or a single clear corneal incision.
Read More